Immunic AG
IMUX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US4525EP1011
- LEI:
- 549300R5T12FW5MEQB20
- Country:
- United States of America
- Address:
- C/O The Corporation Trust Company, 19801 Wilmington
- Website:
- https://imux.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Immunic AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-07 12:30 |
Earnings Release
Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corpor…
|
English | 23.5 KB | |
2025-06-24 12:30 |
Regulatory News Service
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 …
|
English | 15.2 KB | |
2025-06-05 12:30 |
Legal Proceedings Report
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Re…
|
English | 18.3 KB | |
2025-06-02 12:30 |
Regulatory News Service
Immunic to Participate in Investor, Scientific and Industry Conferences in June
|
English | 13.9 KB |
Automate Your Workflow. Get a real-time feed of all Immunic AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Immunic AG via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |